WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication

WuXi Biologics Singapore China

Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats.Finished building will be one of the world's largest modular biologics Drug Product (DP) facilities, and will enhance WuXi Biologics' leadership in end-to-end DP capabilities.View original content:https://www.prnewswire.co.uk/news-releases/wuxi-biologics-singapore-crdmo-hub-advances-with-the-launch-of-modular-drug-product-facility-fabrication-302515756.html